BOSTON, MA--(Marketwire - November 03, 2008) - PHT Corporation, the leading provider of ePRO solutions used in more than 360 clinical trials worldwide continues to see strong market demand for its ePRO products. The company announced one of the most successful fiscal quarters in its history. Among PHT’s significant accomplishments are 18 new trials which involve nearly 4,000 patients worldwide.
